Mepron Related Clinical Trials
Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension [Completed]
The ASAP Study - Therapeutic Efficacy of Atovaquone-proguanil vs. Artesunate-atovaquone-proguanil in Cambodia [Recruiting]
Weekly Dosing of Malarone � for Prevention of Malaria [Completed]
Antiretroviral Drug Interaction Study in Volunteers With HIV [Completed]
Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis [Completed]
Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children [Completed]
A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX [Completed]
A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole [Completed]
A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides [Completed]
A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia [Completed]
An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine [Completed]
Chloroquine Alone or in Combination for Malaria in Children in Malawi [Completed]
Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients [Completed]
Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America [Completed]
A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children [Completed]
A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine [Completed]
A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients [Completed]
Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function [Completed]
Evaluation of the Riamet® Versus Malarone® in the Treatment of Uncomplicated Malaria [Active, not recruiting]
Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP) [Withdrawn]
Target Antigens Induced by Plasmodium Falciparum Sporozoite Immunization Under Chemoprophylaxis [Completed]
Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria [Terminated]
Chemoprophylaxis and Plasmodium Falciparum NF54 Sporozoite Immunization Challenged by Heterologous Infection [Active, not recruiting]
Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function [Terminated]
DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria [Not yet recruiting]
Ototoxicity of Artemether / Lumefantrine (Coartem) and Other Antimalarials [Completed]
Evaluating the Ottawa Malaria Decision Aid [Recruiting]
A Pilot Study to Test Activity of Antimalarial Drugs Against an Induced Malaria Infection in Healthy Volunteers [Completed]
Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria [Completed]
Re-exposure of Human Volunteers to a Heterologous Strain of P. Falciparum Sporozoites [Completed]
|
